Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alfonso Segarra
Rituximab Treatment of Adult Patients With Steroid-Resistant Focal Segmental Glomerulosclerosis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Related publications
1002 Pulse Cyclophosphamide Therapy for Steroid-Resistant Focal Segmental Glomerulosclerosis in Children
Pediatric Research
Child Health
Pediatrics
Perinatology
Response to ‘Treatment of Focal Segmental Glomerulosclerosis’
Kidney International
Nephrology
Focal Segmental Glomerulosclerosis
American Journal of Medicine
Medicine
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports
Nephrology
Galactose Treatment in Focal and Segmental Glomerulosclerosis
Pediatric Nephrology
Child Health
Pediatrics
Perinatology
Nephrology
Genetics of Focal Segmental Glomerulosclerosis
Pediatric Nephrology
Child Health
Pediatrics
Perinatology
Nephrology
Successful Treatment of Recurrent Focal Segmental Glomerulosclerosis With a Low Dose Rituximab in a Kidney Transplant Recipient
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine
Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis
Nephro-Urology Monthly
Urology
The Pathogenesis of Focal Segmental Glomerulosclerosis
Advances in Chronic Kidney Disease
Nephrology